Comparative meta-analysis of prospective studies on urgent revascularization in patients with multivessel disease presenting specifically as Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS), via coronary artery bypass grafting or percutaneous intervention.
This study is a randomized, multicenter, prospective, open clinical trial comparing clinical outcomes 3 months after implanting an On-X mechanical mitral prosthesis in patients with standard anticoagulation ranges versus a lower target.
This is a multicenter, randomized clinical trial evaluating outcomes of transcatheter edge-to-edge tricuspid valve repair compared to optimized medical management in 350 patients with severe tricuspid regurgitation.
Analysis of post-procedure outcomes and mid-term follow-up of TAVI vs. SVA in a U.S. healthcare insurance database for patients with pure aortic insufficiency.
This meta-analysis, encompassing 6 clinical trials, compares percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in cases of left main coronary artery disease or multivessel disease, presenting results stratified according to the SYNTAX score.
This review, published in JACC, addresses the global impact of infections in implanted cardiac electronic devices (CIEDs), providing treatment recommendations and potential improvements in application.
First multicenter randomized clinical trial assessing the outcomes of immediate VA-ECMO implantation compared to an initially conservative strategy (allowing subsequent VA-ECMO if hemodynamic deterioration occurs) in patients with severe or rapidly deteriorating cardiogenic shock.
This single-center study from American evaluates the development of aortic regurgitation (AR) during follow-up after isolated repair of ventricular septal defects (VSDs) to identify predictive factors.
This review paper updates the evidence regarding indications, techniques, and outcomes of concomitant left atrial appendage (LAA) closure in atrial fibrillation patients undergoing cardiac surgery.
This retrospective American study evaluates short- and mid-term outcomes in a cohort of 56,331 patients with severe aortic stenosis and bicuspid aortic valve (BAV) undergoing conventional aortic valve replacement (AVR) or transcatheter implantation (TAVI).
If you wish to receive our monthly newsletter, containing all the news collected on our portal, please fill in your email address and click on the “Subscribe” button.